Here we expect structural changes that could be serious for individual hospitals, especially smaller ones.

The legal changes passed so far and the reforms currently being discussed essentially concern the acute sector. Joachim Ramming: “Even before the pandemic, ways and means were being discussed to make the healthcare market more quality-oriented, more cost-effective and more efficient. Lauterbach will have on MEDICLIN’s business, answered the Chairman of the Board, Dr. When asked what effects the reform of Dr.

MEDICLIN’s strengths lie in rehabilitation and in the interdisciplinary medical care between acute medicine and rehabilitation. Group sales and Group EBIT were thus in line with the guidance for the 2022 financial year,” said Tino Fritz, CFO of MEDICLIN, when presenting the goals achieved for the 2022 financial year. The Group operating result was EUR 19.5 mill., EUR 7.9 mill. In purely operational terms, Group sales improved by EUR 34.6 mill. “The positive development in Group sales is particularly evident when you look at the development without the benefits received under the protective shield in both years. and was thus 4.7% above the previous year’s value. In the 2022 financial year, MEDICLIN achieved Group sales of EUR 704.7 mill. Group sales and Group operating result above previous year − cautious outlook for 2023Īt today’s balance sheet press conference, the Management Board of MEDICLIN Aktiengesellschaft (MEDICLIN) presented the figures for the 2022 financial year and commented on the further development of the Company.

Outlook password manager